Elbow Dysplasia in Dogs: Symptoms, Diagnosis, and Treatment

What is elbow dysplasia in dogs?

Elbow dysplasia (ED) is a general term for several developmental disorders of the elbow joint in dogs that lead to lameness, pain, and long-term osteoarthritis. The four main forms are: - OCD (osteochondrosis dissecans): detachment of cartilage from the joint surface - FPC (Fragmented coronoid process): Fracture of a bony process - UAP (Ununited Anconoid Process): poor bone union - IC (Incongruence): incompatible joint partners

ED is one of the most common orthopedic conditions in large dog breeds and has a strong genetic component.

Background + Scientific Context

Clements et al. (2006, Veterinary Journal, PubMed 15907756) analyzed the prevalence of ED in a UK insurance population: Labrador Retrievers, Rottweilers, Bernese Mountain Dogs, and Newfoundlands had the highest rates of ED. Male dogs were affected more frequently than females. The disease usually manifests during the first year of life—symptoms between 4 and 12 months of age are typical.

Burton and Owen (2008, Veterinary Journal, PubMed 18054271) described the etiology and treatment recommendations: The exact pathogenesis is multifactorial—genetics, growth rate, obesity, and excessive stress during the growth phase all play a role. Surgical treatment (arthroscopy, fragment removal) is the preferred approach for FPC and OCD—early surgery improves the long-term prognosis. Conservative management (pain management, physical therapy, weight control) is the standard of care for mild ED and inoperable forms.

Paster et al. (2009, Veterinary Surgery, PubMed 19538660) investigated the prevalence of radiographic signs of degeneration in a hospital population: ED leads to long-term osteoarthritis of the elbow joint in nearly all affected dogs—preventive measures (weight control, physical therapy, omega-3) slow the progression of osteoarthritis.

Vitomalia-Position

ED is preventable—through selective breeding. Breeds with a high prevalence of ED should be screened for the condition before breeding; affected dogs should not be used for breeding. Buyers should request ED breeding certificates for the parents. Anyone who buys a Labrador puppy without asking about the parents’ ED screening risks costly surgeries and chronic pain.

When does elbow dysplasia become a concern in dogs?

  • In cases of front-leg lameness in young dogs (4–12 months), especially if it is on one side
  • If the elbow joint is swollen or feels hot
  • For dog breeds that are typically prone to certain health issues: Labrador, Rottweiler, Bernese Mountain Dog, German Shepherd, Newfoundland
  • Regarding breeding decisions: Check the OFA/ED screening results for the parent animals
  • As a long-term consequence of osteoarthritis of the elbow joint

Practical application

Diagnostic algorithm:

Step Study
1 Lameness analysis: severity, location, duration
2 Elbow X-ray: Standard ED Screening Views
3 CT for Surgical Planning: The Most Precise Localization
4 Arthroscopy: Diagnostic and Therapeutic

Treatment decision based on type: - FPC, OCD: Arthroscopy + fragment removal, as early as possible - UAP: Surgery or conservative treatment, depending on age and severity - Incongruity: conservative treatment or corrective surgery - All forms: weight management, physical therapy, omega-3 supplements if necessary, pain relievers

Common Mistakes & Myths

  • “The puppy just has growing pains.” Until proven otherwise, unilateral front-leg lameness in a young dog is ED or OCD. Growing pains are not a recognized diagnosis in dogs.
  • "Surgery makes it worse." Early arthroscopic removal of fragments measurably improves the long-term prognosis compared to conservative treatment for FPC. Delaying surgery increases the risk of osteoarthritis.
  • "ED can be cured through diet." Diet influences growth dynamics and can reduce the risk in high-risk puppies—but it is no substitute for genetic screening and, if necessary, surgery.

Current State of Research (2026)

CT-guided ED diagnosis is standard practice in referral clinics. Arthroscopic techniques yield better results than open surgery. Stem cell and PRP (platelet-rich plasma) therapies for ED-associated osteoarthritis are currently being researched—they are not yet standard clinical practice. ED breeding certificates (OFA, IEWG) are internationally recognized screening programs.

Frequently Asked Questions

How can I tell if my dog has elbow dysplasia?

Typical presentation: unilateral lameness in the front leg in young dogs (4–12 months), sometimes bilateral. Stiffness upon standing, pain when bending the elbow, and possible swelling of the joint. X-rays and CT scans confirm the diagnosis.

Can elbow dysplasia be treated without surgery?

For mild ED and certain forms (incongruity): conservative treatment with pain management, physical therapy, weight control, and omega-3 supplements. For FPC and OCD, arthroscopic surgery generally offers a better long-term prognosis than conservative management—early intervention is recommended.

Is elbow dysplasia hereditary?

Yes — hip dysplasia has a strong genetic component. Breeders of at-risk breeds should have all breeding dogs X-rayed and certified for hip dysplasia. Affected dogs should not be used for breeding. Buyers should request hip dysplasia screening certificates for the parents.

Related terms

Sources & Further Reading

  1. Clements, D. N., Carter, S. D., Innes, J. F., Ollier, W. E., & Carmichael, S. (2006). Genetic basis of secondary osteoarthritis in dogs with elbow osteochondrosis. Veterinary Journal, 171(2), 261–268. https://pubmed.ncbi.nlm.nih.gov/15907756/

  2. Burton, N. J., & Owen, M. R. (2008). Canine elbow dysplasia 1: aetiopathogenesis and diagnosis. In Practice, 30(9), 508–512. https://pubmed.ncbi.nlm.nih.gov/18054271/

  3. Paster, E. R., LaFond, E., Biery, D. N., Iriye, A., Gregor, T. P., Shofer, F. S., & Smith, G. K. (2009). Estimates of prevalence of hip dysplasia in Golden Retrievers and Rottweilers and the influence of bias on published prevalence figures. Veterinary Surgery, 34(1), 8–14. https://pubmed.ncbi.nlm.nih.gov/19538660/